~~<i id='A70194A968'><strike id='A70194A968'><tt id='A70194A968'><pre id='A70194A968'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

Wikipedia

author：comprehensive 2025-09-28 02:47:30 - browse：23664

The FDA building -- First Opinion coverage from STAT — Adobe

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

entertainment

hotspot

focus

Wikipedia

hotspot

Wikipedia

NeurocrineBiosciencesdecidedtojoinPhRMA.AdobeWASHINGTON—NeurocrineBiosciences,abiotechcompanybasedin

WSS

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

A clever new way to fix Medicaid and graduate medical education

HPV cancer vaccine study demonstrates efficacy

6 phony surgeries that take placebo to the extreme

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Antivenom research: Lessons from HIV applied in search for universal antidote

knowledge

Wikipedia

entertainment

Virginia high school admissions case could be legal follow

Obesity drugs seen as possible treatment for liver disease MASH

Peter Hotez and the public health issue of online harassment

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Medicare details structure of new drug price negotiation program

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

The cancer drug shortage isn’t new — and neither are the solutions

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Drug repurposing or repositioning? The language matters

Victims of gun violence feel impacts long after bullet wound

hotspot

A clever new way to fix Medicaid and graduate medical education

Senate panel clears PBM, hopsital reforms

The Sacklers, horror, and ‘The Fall of the House of Usher’

Medicare will require more price transparency from hospitals

Excited delirium, Elijah McClain, and emergency physicians

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

focus

Wikipedia

hotspot

Wikipedia